Pictured: Joao Xavier & Eric Pamer
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 10, 2014

Clostridium difficile infections are a growing problem, but MSK researchers are looking for innovative ways to prevent and treat them.

RISE Program Clinical Director Debra Mangino discusses next steps with a patient.
In the Clinic
By Andrea Peirce, BA, Writer/Editor  |  Friday, October 31, 2014

The team of experts in our RISE Program tailor each woman’s surveillance plan based on the latest findings in breast cancer risk, prevention, and treatment.

Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, October 20, 2014

Medical oncologist Paul Sabbatini demystifies common misconceptions surrounding clinical trials.

DNA wrapped around histones
Decoder
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, October 14, 2014

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.

Pictured: Ping Chi
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, October 9, 2014

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

Pictured: Robin Roberts & Tonya Samuel
SUPPORT
By Maureen Salamon, BA, Freelance Writer  |  Friday, October 3, 2014

For people undergoing bone marrow or stem cell transplants, being isolated from friends, family, and everyday life can make recovery more difficult.

Event
By Jim Stallard, MA, Writer/Editor  |  Thursday, September 25, 2014

Transplant patients at Memorial Sloan Kettering gave support to bone marrow donation efforts with their own “walk” inside the hospital.

Pictured: Paul Sabbatini
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Wednesday, September 24, 2014

Medical oncologist Paul Sabbatini sheds light on how phase I clinical trials are conducted at Memorial Sloan Kettering and how to determine whether patients may be eligible for one.

Pictured: Experimental Brain Tumor
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, September 18, 2014

Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.

Thoracic surgeon Bernard Park.
Ask the Expert
By Andrea Peirce, BA, Writer/Editor  |  Thursday, August 28, 2014

Less trauma and faster recovery are among the reasons that thoracic surgeon Bernard Park says people should consider robotic surgery for removing a cancer in the chest.

pictured: David Jones
Q&A
By Christina Pernambuco-Holsten, MA, Managing Web Editor  |  Wednesday, August 13, 2014

David Jones, Chief of the Thoracic Surgery Service, talks about what makes MSK thoracic surgeons special and where he believes the future of treatment for cancers of the lung and esophagus is headed.

Pictured: Richard O’Reilly
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Thursday, July 31, 2014

A study shows that treatment of severe combined immunodeficiency (SCID) with stem cell transplantation is very effective, especially if done early.

Pictured: Robotic surgery
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, July 24, 2014

Memorial Sloan Kettering researchers have found that the use of surgical robots does not lead to better outcomes in patients undergoing radical cystectomy for bladder cancer, bringing into question the added costs of the tools.

Pictured: Gabriela Chiosis
Finding
By Celia Gittelson, BA  |  Thursday, July 17, 2014

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.

Pictured: Vivian Strong
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, June 24, 2014

Memorial Sloan Kettering diagnoses and treats more people with stomach cancer than any other cancer center in the nation.

Center News

Stay Informed

Get the latest information about cancer care and research every month.